Objective: Drug nanoparticles offer a versatile platform for enhancing the dissolution rate and bioavailability of poorly water soluble drugs The present study was aimed to design and develop dasatinib (DAS) loaded Poly lactide co glycolic acid (PLGA) to enhance the dissolution rate and to study the effect of formulation variables for the BCS class II drug dasatinib for the treatment of chronic myeloid leukemia. Methods: The DAS loaded Nps were prepared by using modified double emulsion solvent evaporation method (DESE) using different stabilizers, the formulated Nps were characterized for particle size, zeta potential, Poly Dispersity Index, Surface morphology, Drug entrapment and Invitro drug release. Results: The DAS loaded NP s showed the lowest particles size of 123 nm and zeta potential of – results of Pluronic F68 loaded NP showed the lowest particle size of – and highest zeta potential of --. Surface morphology of NPs with DMAB showed distinct smooth spherical particles with the size range of 50nm. Morphology of Pluronic F68 formulated NPs showed the high degree of aggregation. In vitro drug release showed up to 24hrs in a sustained manner. Conclusion: The result of our study indicates the use of PLGA as a sustained release polymer and using DMAB as a stabilizer for better stable formulation.
Cite this article:
Shyam S Kumar, G. Gopalakrishnan, N. L. Gowrishankar. Design, Optimization and in vitro Characterization of Dasatinib loaded PLGA Nano carrier for Targeted cancer therapy: A Preliminary Evaluation. Research Journal of Pharmacy and Technology. 2021; 14(4):2095-0. doi: 10.52711/0974-360X.2021.00371
Shyam S Kumar, G. Gopalakrishnan, N. L. Gowrishankar. Design, Optimization and in vitro Characterization of Dasatinib loaded PLGA Nano carrier for Targeted cancer therapy: A Preliminary Evaluation. Research Journal of Pharmacy and Technology. 2021; 14(4):2095-0. doi: 10.52711/0974-360X.2021.00371 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-4-47
1. World Health Organization. Global Health Observatory. Geneva: who.int/gho/database/ en/ Accessed June 21, 2018.
2. Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q.1971;49:509-538.
3. Stewart BW, Wild CP, editors. World cancer report 2014
4. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: A synthetic analysis. Lancet Glob Health. 2016 Sep;4(9): e609-16.
5. Yates L. R. and Campbell P. J. (2012) Evolution of the cancer genome. Nat Rev Genet 13: 795-806
6. Caldas C. Cancer sequencing unravels clonal evolution. Nat Biotechnol. 2012; 30: 408-410
7. Ding L., Ley T. J., Larson D. E., Miller C. A., Koboldt D. C., et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole-genome sequencing. Nature 2012; 481: 506-510
8. Meyer J. A., Wang J., Hogan L. E., Yang J. J., Dandekar S., et al. Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nat Genet 2013; 45: 290-294
9. Mardis E. R. Genome sequencing and cancer. Curr Opin Genet Dev 2012; 22: 245-250
10. Gerlinger M., Rowan A. J., Horswell S., Larkin J., Endesfelder D., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-892
11. Landau D. A., Carter S. L., Stojanov P., McKenna A., Stevenson K., et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 2019; 152: 714-726
12. Shen Z, et al. Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier. European Journal of Pharmaceutical Sciences. 2008; 35: 271-82
13. Jessy Shaji, Monika Kumbhar. Linezolid Loaded Biodegradable Polymeric Nanoparticles Formulation and Characterization. Research Journal of Pharmaceutical Dosage Form and Technology.5 2018; 10(4): 272-278
14. Borkar Sudarshan, et al., Tamoxifen Citrate Loaded Solid Lipid Nanoparticles- A Novel Approach in The Treatment of ER+ Breast Cancer. Research Journal of Pharmaceutical Dosage Form and Technology. 2009; 1(2): 143-149
15. Vipul V. Jambukiya, et al., Enhancement of Solubility and Dissolution Rate of Poorly Water-Soluble Drug by Using Modified Guar Gum. Asian Journal of Research in Pharmaceutical Sciences. 2013; 3(1): 25-30.
16. Korsmeyer, R.W., Gurny, R., Doelker, E., Buri, P. and Peppas, N.A. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm,1983; 15: 25-35
17. Mayank Shah, Kamla Pathak. Solid Lipid Nanoparticles of Simvastatin: Pharmacokinetic and Biodistribution Studies on Swiss albino mice. Research Journal of Pharmaceutical Dosage Form and Technology. 2012; 4(6): 336-342.
18. Venkatesh Gavini, M. Srinivasa Murthy, P. Kiran Kumar. Formulation and Invitro Evaluation of Nanoparticulate Drug Delivery System Loaded With 5-Fluorouracil Research Journal of Pharmaceutical Dosage Form and Technology. 2014; 6(4): 243-248..
19. Hariharan S, Bhardwaj V, Bala I, Sitterberg J, Bakowsky U, et al. Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy. Pharm Res 2016; 23: 184–195
20. Vinay C H, et al., Development and Characterization of Orange Peel Extract Based Nanoparticles. Asian Journal of Pharmaceutical Research. 2018; 8(2): 71-77.
21. K Kumaresn, et al., Toxicity Effect of Copper oxide Nanoparticles on Artemia salina. Research Journal of Pharmacology and Pharmacodynamics. 2015; 7(2): 53-60.
22. Eun Chul Cho, Jingwei Xie, Patricia A. Wurm, and Younan. Understanding the Role of Surface Charges in Cellular Adsorption versus Internalization by Selectively Removing Gold Nanoparticles on the Cell Surface with a I2/KI Etchant. Nano Letters 2009; 9(3): 1080-1084.
23. A. Ramankannan, et al., Preparation and Characterization of Pectinase bound Co-precipitated Magnetic Nanoparticles. Asian Journal of Pharmacy and Technology. 2013; 3(4): 175-180.
24. Karthick J, et al., In-Silico Analysis of Targeted Drug Delivery to Hepatic Cells using Lipid Nano-Particles to Treat Liver Diseases. Asian Journal of Pharmacy and Technology. 2013; 3(4): 189-194
25. Zhang, Y, Huo, M., Zhou, J., Zou, A, et al. DD Solver: An add-in program for modelling and comparison of drug dissolution profiles. AAPS Journal, 2010; 12:263-271.